Indication
Behavioral Symptoms
4 clinical trials
4 products
Clinical trial
A Phase 2, Double-blind, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Oral Administration of Ganaxolone in Women With Postpartum DepressionStatus: Completed, Estimated PCD: 2019-07-05
Product
PlaceboProduct
GanaxoloneClinical trial
A Phase 2A, Double-blind, Placebo-controlled, Multiple-dose Escalation Study to Evaluate Safety, Pharmacokinetics and Efficacy of Intravenously Administered Ganaxolone in Women With Postpartum DepressionStatus: Completed, Estimated PCD: 2019-05-10
Clinical trial
A Double Blind, Placebo Controlled, Fixed-Flexible Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi SyndromeStatus: Recruiting, Estimated PCD: 2024-01-18
Product
GuanfacineClinical trial
Single-site, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Dronabinol for the Treatment of Agitation in Outpatient With DementiaStatus: Withdrawn, Estimated PCD: 2025-11-01
Product
Dronabinol